Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Klinge focus continues on novel antitumor/immunosuppressive compounds

July 16, 1999

Another series of apoptotic agents designed under Cell Pathways, U. of Arizona collaboration

July 16, 1999

Novel antitumor agents from Rutgers act as topoisomerase poisons

July 15, 1999

Klinge presents new compounds with both antitumor and immunosuppressive effects

July 15, 1999

Antitumor spectrum of Sch-66336 determined in human tumor cloning assay

July 14, 1999

Bristol-Myers Squibb patents new series of CDK inhibitors

July 14, 1999

Tetrionics will supply 2ME2 for EntreMed's preclinical testing program

July 14, 1999

Onconase/interferon combination exerts synergistic antitumor activity in vitro

July 14, 1999

NeXstar begins enrolling patients in U.S. phase I trial of NX-211

July 14, 1999

Selected purine analogues tested as angiogenesis inhibitors

July 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...